<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="42071">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02156024</url>
  </required_header>
  <id_info>
    <org_study_id>JDZX2012115</org_study_id>
    <nct_id>NCT02156024</nct_id>
  </id_info>
  <brief_title>The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Institute of Hypertension</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Institute of Hypertension</source>
  <oversight_info>
    <authority>China: State Administration of Traditional Chinese Medicine</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is

        1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of
           masked hypertensive patients below 45.

        2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>blood pressure</measure>
    <time_frame>March 1,2015</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Masked Hypertension</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo drink, 1 dose at a time, twice a day, duration: 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gastrodia and Uncaria Drink</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 2 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gastrodia and Uncaria Drink</intervention_name>
    <description>Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 2 weeks</description>
    <arm_group_label>Gastrodia and Uncaria Drink</arm_group_label>
    <other_name>tianma gouteng drink</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 to 45

          -  didn't use any anti-hypertension drugs within 2 weeks

          -  stage 1 masked hypertensive patients, which means clinic blood pressure&lt;140/90
             mmHg,however the daytime(8:00-18:00) 24h ambulatory blood pressure between 135/85 and
             150/95mmHg

          -  be willing to participate in the trials and  able to finish clinic visit

        Exclusion Criteria:

          -  secondary hypertension

          -  be allergic to the clinical trial medicine

          -  occurrence of stroke, CKD, myocardial infarction within 2 years

          -  dysfunction of liver or kidney and fundus hemorrhage

          -  arrhythmia

          -  ALT, AST, TBL upper the twice of normal range, Scr≥2.0mg/dl, K+≥5.5mmol/L, Urine
             protein≥2+

          -  psychiatric disorders

          -  pregnant, breastfeeding

          -  other serious conditions in which is not fit for the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yan Li, doctor</last_name>
    <phone>021-64370045</phone>
    <phone_ext>663228</phone_ext>
    <email>liyanshcn@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ruijin Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Li, doctor</last_name>
      <phone>021-64370045</phone>
      <phone_ext>663228</phone_ext>
      <email>liyanshcn@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Yan Li, docter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.satcm.gov.cn/web2010/zhengwugongkai/kejiguanli/keyanguanli/2012-06-01/15710.html</url>
    <description>co-worker teams of clinical trials provided by the state administration of traditional chinese medicine of china</description>
  </link>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>May 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Institute of Hypertension</investigator_affiliation>
    <investigator_full_name>Cheng Yibang</investigator_full_name>
    <investigator_title>master</investigator_title>
  </responsible_party>
  <keyword>clinical trials</keyword>
  <keyword>Gastrodia and Uncaria Drink</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
